GR3015812T3 - Anti-inflammatory analgesic patch. - Google Patents

Anti-inflammatory analgesic patch.

Info

Publication number
GR3015812T3
GR3015812T3 GR950400942T GR950400942T GR3015812T3 GR 3015812 T3 GR3015812 T3 GR 3015812T3 GR 950400942 T GR950400942 T GR 950400942T GR 950400942 T GR950400942 T GR 950400942T GR 3015812 T3 GR3015812 T3 GR 3015812T3
Authority
GR
Greece
Prior art keywords
reserver
drug
inflammatory analgesic
analgesic patch
acid
Prior art date
Application number
GR950400942T
Other languages
English (en)
Inventor
Akihito Oji
Yukihiro Tada
Noriyuki Sasaki
Mitsuo Mizumura
Original Assignee
Lederle Japan Ltd
Teikoku Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lederle Japan Ltd, Teikoku Seiyaku Kk filed Critical Lederle Japan Ltd
Publication of GR3015812T3 publication Critical patent/GR3015812T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GR950400942T 1989-12-25 1995-04-17 Anti-inflammatory analgesic patch. GR3015812T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1332599A JP2839164B2 (ja) 1989-12-25 1989-12-25 消炎鎮痛貼付剤

Publications (1)

Publication Number Publication Date
GR3015812T3 true GR3015812T3 (en) 1995-07-31

Family

ID=18256747

Family Applications (1)

Application Number Title Priority Date Filing Date
GR950400942T GR3015812T3 (en) 1989-12-25 1995-04-17 Anti-inflammatory analgesic patch.

Country Status (10)

Country Link
US (1) US5116621A (el)
EP (1) EP0436217B1 (el)
JP (1) JP2839164B2 (el)
KR (1) KR0180007B1 (el)
AT (1) ATE120648T1 (el)
CA (1) CA2033122C (el)
DE (1) DE69018424T2 (el)
DK (1) DK0436217T3 (el)
ES (1) ES2070261T3 (el)
GR (1) GR3015812T3 (el)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462744A (en) * 1989-12-01 1995-10-31 Boehringer Ingelheim Kg Transdermal system for the administration of pharmacological compounds under pH-controlled conditions
US5902600A (en) * 1992-12-21 1999-05-11 Healthpoint, Ltd. Hydrogel polymer wound dressing
AU667161B2 (en) * 1993-04-28 1996-03-07 Daiichi Pharmaceutical Co., Ltd. Butyrophenone transdermal compositions
US5409691A (en) * 1993-10-18 1995-04-25 Swain; Dan E. Solution comprising aluminum acetate and glycerin
US5733900A (en) * 1994-04-21 1998-03-31 Hisamitsu Pharmaceutical Co., Inc. Percutaneous administration base composition and percutaneous administration medicinal composition comprising said base composition and medicine
JPH10120560A (ja) * 1996-08-26 1998-05-12 Sankyo Co Ltd ロキソプロフェン含有外用製剤
US5800832A (en) * 1996-10-18 1998-09-01 Virotex Corporation Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
JPH10265374A (ja) * 1997-03-24 1998-10-06 Saitama Daiichi Seiyaku Kk 外用剤組成物及びその製造方法
US20050048102A1 (en) * 1997-10-16 2005-03-03 Virotex Corporation Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US6211296B1 (en) 1998-11-05 2001-04-03 The B. F. Goodrich Company Hydrogels containing substances
JP4584381B2 (ja) * 1999-07-30 2010-11-17 久光製薬株式会社 フェルビナク含有貼付剤
US6698162B2 (en) 2000-03-23 2004-03-02 Teikoku Pharma Usa, Inc. Methods of producing a terminally sterilized topical patch preparation
JP4648518B2 (ja) * 2000-06-01 2011-03-09 帝國製薬株式会社 ４−ビフェニル酢酸含有貼付剤
US20030216758A1 (en) * 2001-12-28 2003-11-20 Angiotech Pharmaceuticals, Inc. Coated surgical patches
TWI412570B (zh) * 2004-04-27 2013-10-21 Showa Denko Kk Adhesive for patch and method for producing the same
TWI414320B (zh) * 2004-05-13 2013-11-11 Hisamitsu Pharmaceutical Co 含有非類固醇系消炎鎮痛劑之外用經皮製劑
MX2009000745A (es) * 2006-07-21 2009-04-16 Biodelivery Sciences Int Inc Dispositivos de suministro transmucosa con admision mejorada.
KR100867262B1 (ko) 2007-01-17 2008-11-06 대화제약 주식회사 펠비낙을 함유하는 플라스터 조성물
CN102341124A (zh) * 2009-03-11 2012-02-01 兴和株式会社 含有镇痛-抗炎症剂的外用剂
US8701671B2 (en) 2011-02-04 2014-04-22 Joseph E. Kovarik Non-surgical method and system for reducing snoring
US9549842B2 (en) 2011-02-04 2017-01-24 Joseph E. Kovarik Buccal bioadhesive strip and method of treating snoring and sleep apnea
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
SG10201610097WA (en) 2011-08-18 2017-01-27 Biodelivery Sciences Int Inc Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
JP2012144562A (ja) * 2012-04-17 2012-08-02 Teikoku Seiyaku Co Ltd 貼付剤
JP5949285B2 (ja) * 2012-07-31 2016-07-06 ライオン株式会社 貼付剤
EP2968652B1 (en) 2013-03-13 2020-07-22 Avery Dennison Corporation Improving adhesive properties
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
JP7219623B2 (ja) * 2018-01-30 2023-02-08 日東電工株式会社 経皮吸収型製剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5842168B2 (ja) * 1974-12-20 1983-09-17 トウコウヤクヒンコウギヨウ カブシキガイシヤ 局所用剤の製造方法
JPS59222409A (ja) * 1983-06-01 1984-12-14 Nippon Redarii Kk 消炎鎮痛ゲル軟膏剤
JPS60188315A (ja) * 1984-03-07 1985-09-25 Yamanouchi Pharmaceut Co Ltd グリチルレチン酸配合鎮痒プラスター
JPS60209515A (ja) * 1984-04-03 1985-10-22 Hokuriku Seiyaku Co Ltd 消炎鎮痛クリ−ム剤
US4954343A (en) * 1986-03-29 1990-09-04 Nitto Electric Industrial Co., Ltd. Dermal pharmaceutical preparations
AU607172B2 (en) * 1986-12-22 1991-02-28 Cygnus, Inc. Diffusion matrix for transdermal drug administration
JPH0696529B2 (ja) * 1987-03-31 1994-11-30 積水化学工業株式会社 ニトログリセリン貼付剤およびその製造方法
EP0303445A1 (en) * 1987-08-13 1989-02-15 Walton S.A. Clebopride transdermal patch
JPS6485913A (en) * 1987-09-26 1989-03-30 Saitama Daiichi Seiyaku Kk Anti-inflammatory analgesic plaster containing 4-biphenylylacetic acid
GB2217595B (en) * 1988-04-21 1991-11-20 American Cyanamid Co Antiinflammatory gel

Also Published As

Publication number Publication date
JPH03193728A (ja) 1991-08-23
EP0436217B1 (en) 1995-04-05
EP0436217A2 (en) 1991-07-10
US5116621A (en) 1992-05-26
ATE120648T1 (de) 1995-04-15
CA2033122C (en) 2003-08-19
KR0180007B1 (ko) 1999-03-20
KR910011248A (ko) 1991-08-07
CA2033122A1 (en) 1991-06-26
JP2839164B2 (ja) 1998-12-16
DE69018424D1 (de) 1995-05-11
ES2070261T3 (es) 1995-06-01
DE69018424T2 (de) 1995-09-21
EP0436217A3 (en) 1991-09-25
DK0436217T3 (da) 1995-05-01

Similar Documents

Publication Publication Date Title
EP0436217A3 (en) Anti-inflammatory analgesic patch
MX9308199A (es) Inhibidores de enzima.
NO931766D0 (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
ATE149349T1 (de) Einarbeitung eines poly-n-vinylamids in ein transdermales system
ATE361093T1 (de) Selektiv auf die leber wirkende pharmazeutisch aktive substanz
HK1040631A1 (en) Pharmaceutical compositions based on alpha-cyclodextrin for the oral administration of lh-rh analogues.
MY102378A (en) Transdermal delivery system.
ES2124320T3 (es) Desinfectante de yodo y resina y un procedimiento para su preparacion.
ATE223745T1 (de) Zusammensetzung zur verbesserten elektroübertragunslieferung von wirkstoff
CA2158475A1 (en) Composition and method for reducing toxicity of biologically-active factors
AU7807791A (en) Method of treating impotence
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
GEP20002332B (en) Cefalosporin Derivatives
CA2202531A1 (en) Lyophilizate of lipid complex of water insoluble camptothecins
MXPA02012075A (es) Composicion para mediar el dolor y aparato y metodo para utilizarla.
CA2251966A1 (en) Transdermally administered dextromethorphan as antitussive agent
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
EP0328924A3 (en) Thienotriazolodiazepine compounds and pharmaceutical uses thereof
EP0565146A3 (en) Use of a thioester for preparing pharmaceutical compositions for the treatment of ischemia and reperfusion syndromes
EP0353474A3 (en) Glycerin derivative and its pharmacological use
EP0345883A3 (en) Use of dapiprazole for the manufacture of a pharmaceutical composition inhibiting the development of tolerance in the analgesic treatment with morphine
MY132436A (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
CA2103707A1 (en) Treatment of non-small cell lung carcinoma
CA2090234A1 (en) Method for providing improved analgesic effect
EP0348664A3 (en) Pharmaceutical compositions containing monoacetoacetins for treating tumours